Cite

HARVARD Citation

    Yu, P. et al. (n.d.). Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin. Clinical infectious diseases. pp. S57-S64. [Online]. 
  
Back to record